Surgery Partners, Inc. (NASDAQ:SGRY – Get Free Report)’s share price gapped up prior to trading on Monday. The stock had previously closed at $15.75, but opened at $19.47. Surgery Partners shares last traded at $22.9950, with a volume of 114,561 shares.
Surgery Partners News Roundup
Here are the key news stories impacting Surgery Partners this week:
- Positive Sentiment: HealthSpan Partners agreed to acquire Surgery Partners for $23.50 per share in cash, valuing the transaction at approximately $5.7 billion in enterprise value. The offer pushed SGRY shares sharply higher toward the proposed deal price. The transaction is expected to close in the first quarter of 2027, subject to customary conditions and approvals. HealthSpan acquisition announcement
- Neutral Sentiment: With the shares trading close to the $23.50 cash offer, analysts and commentators say the remaining potential gain is limited unless a competing bid emerges or the transaction terms improve. Investors are therefore focused on deal completion rather than Surgery Partners’ standalone operating performance. Surgery Partners buyout analysis
- Negative Sentiment: StoneX downgraded SGRY from Strong Buy/Buy to Hold, reflecting the reduced upside after the buyout-related rally and the stock’s proximity to the offer price. StoneX downgrade
- Negative Sentiment: Several law firms have announced investigations into the proposed sale, examining whether the $23.50 price fairly values Surgery Partners, whether insiders received undue benefits, and whether the board adequately pursued alternatives. These actions could create deal uncertainty, although they do not themselves indicate that the transaction will be blocked. Shareholder investigation
Analyst Ratings Changes
A number of brokerages have issued reports on SGRY. Cantor Fitzgerald lowered shares of Surgery Partners from an “overweight” rating to a “hold” rating in a research report on Monday. Zacks Research cut Surgery Partners from a “strong-buy” rating to a “hold” rating in a research note on Monday, August 10th. Stonex Financia lowered Surgery Partners from a “strong-buy” rating to a “hold” rating in a research note on Tuesday. Raymond James Financial set a $23.50 price objective on Surgery Partners in a research note on Monday. Finally, TD Cowen reaffirmed a “buy” rating and issued a $19.00 price objective on shares of Surgery Partners in a report on Friday, September 18th. Five investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $19.91.
Check Out Our Latest Stock Analysis on Surgery Partners
Surgery Partners Stock Up 0.5%
The firm’s fifty day simple moving average is $14.57 and its 200 day simple moving average is $14.53.
Surgery Partners (NASDAQ:SGRY – Get Free Report) last issued its quarterly earnings results on Monday, August 10th. The company reported $0.10 earnings per share for the quarter, topping analysts’ consensus estimates of $0.06 by $0.04. The firm had revenue of $848.90 million for the quarter, compared to the consensus estimate of $830.03 million. The business’s revenue was up 2.7% on a year-over-year basis. During the same period last year, the company posted $0.17 EPS. On average, equities research analysts predict that Surgery Partners, Inc. will post 0.25 earnings per share for the current year.
Insider Buying and Selling at Surgery Partners
In other Surgery Partners news, Director Teresa DeLuca bought 10,000 shares of the business’s stock in a transaction that occurred on Tuesday, August 18th. The shares were acquired at an average cost of $14.35 per share, for a total transaction of $143,500.00. Following the transaction, the director directly owned 66,843 shares in the company, valued at approximately $959,197.05. This represents a 17.59% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 2.00% of the company’s stock.
Hedge Funds Weigh In On Surgery Partners
Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Public Employees Retirement System of Ohio acquired a new position in shares of Surgery Partners during the second quarter worth $38,000. PNC Financial Services Group Inc. increased its holdings in Surgery Partners by 239.6% in the first quarter. PNC Financial Services Group Inc. now owns 2,907 shares of the company’s stock valued at $35,000 after purchasing an additional 2,051 shares during the period. Fifth Third Bancorp raised its position in Surgery Partners by 5,324.0% during the 1st quarter. Fifth Third Bancorp now owns 4,068 shares of the company’s stock worth $48,000 after purchasing an additional 3,993 shares during the last quarter. Empowered Funds LLC bought a new position in Surgery Partners during the 2nd quarter worth $216,000. Finally, State of Wyoming acquired a new position in Surgery Partners during the 2nd quarter worth about $262,000.
About Surgery Partners
Surgery Partners, Inc is a U.S.-based healthcare services company that operates and manages ambulatory surgery centers and surgical hospitals. The company works with physicians, health systems and other healthcare providers to deliver outpatient surgical care in facilities designed for same-day procedures.
Its facilities provide surgical services across specialties such as orthopedics, pain management, ophthalmology, gastroenterology, urology, gynecology and general surgery. Surgery Partners also supports its operations with clinical, administrative and revenue-cycle services intended to help physicians and facility partners manage patient care and practice operations.
Founded in 2004 and headquartered in Brentwood, Tennessee, Surgery Partners has expanded its platform through acquisitions, joint ventures and other partnerships.
Featured Stories
- Five stocks we like better than Surgery Partners
- These 3 New ETFs Are Turning Heads—Are They Worth Buying?
- Coca-Cola Stock Is Everything AI Isn’t—And That’s Its Biggest Strength
- Apple’s Foldable iPhone Sold Out in Minutes, But Wall Street Has Questions
- Netflix Is Making Big Changes, But Can It Fix What’s Really Hurting Growth?
Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.
